The efficacy and safety of apatinib in patients with heavily pretreated end-stage cancer: a retrospective study

BACKGROUND: Anti-angiogenesis therapy has been a vital treatment option in a variety of cancers. Assessing the efficacy and safety of apatinib in patients with heavily pretreated end-stage cancer is essential. METHODS: Thirty patients with end-stage cancer who were heavily pretreated were enrolled i...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhenyu, Zhou, Xiaoshu, Wang, Shuai, Shi, Liangliang, Meng, Rui, Dai, Xiaofang, Liu, Yi, Lin, Xueke, Xiao, Yong, Peng, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174995/
https://www.ncbi.nlm.nih.gov/pubmed/37180651
http://dx.doi.org/10.21037/tcr-22-2080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174995/
https://www.ncbi.nlm.nih.gov/pubmed/37180651
http://dx.doi.org/10.21037/tcr-22-2080

Ejemplares similares